Literature DB >> 14499685

The impact of the Dornier Compact Delta lithotriptor on the management of primary ureteric calculi.

G Nabi1, O Baldo, J Cartledge, W Cross, A D Joyce, S N Lloyd.   

Abstract

OBJECTIVE: To assess the effectiveness of the Dornier Compact Delta lithotriptor on the management of in situ primary ureteric stones. PATIENTS AND METHODS: 137 patients with primary ureteric stones were treated at a tertiary urological center using the latest Dornier Compact Delta lithotriptor between January 1999 and January 2002. Effectiveness of lithotripsy, retreatment rate, reasons for failure and complications were assessed.
RESULTS: 102 males and 35 females with primary ureteric stones underwent ESWL treatment at our center. 74 patients had upper, 37 middle and 26 lower ureteric locations respectively. Mean stone size was 10 mm (range 8-25 mm). Mean numbers of sessions required were 1.8 (range 1-3). The retreatment rate was 33% in upper ureteric, 29% in mid ureteric and 26% in lower ureteric locations respectively. Complete clearance rate at 3 months was 86% for upper ureteric, 79% for mid ureteric and 79% for lower ureteric. 29 patients had auxiliary treatment in the form of double J ureteric stenting or percutaneous nephrostomies. 26 patients failed treatment and underwent ureteroscopic or ante grade percutaneous removal. Stone size was the only significant factor correlating with failure. The mean size of stones in the successful group was 12 mm as compared to 17 mm in failure group. The likelihood of success following a failed second session (no disintegration or disintegration with fragments more than 6 mm) of treatment was 13.4%. Complications including, steinstrasse, colic, UTI and petechial haemorrhage were seen in 35 patients. One patient developed pyonephrosis and subsequently required nephrectomy.
CONCLUSION: An electromagnetic shock wave lithotriptor using the EMSE-150 shock wave emitter is an effective in situ treatment of primary ureteric stones. Patients with large stone size are likely to have a higher retreatment rate, more auxiliary procedures and complications. Having a failed second treatment session, the likelihood of a successful outcome after third session of ESWL is poor.

Entities:  

Mesh:

Year:  2003        PMID: 14499685     DOI: 10.1016/s0302-2838(03)00312-9

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

Review 1.  The efficacy and safety of extracorporeal shock wave lithotripsy in children.

Authors:  Yılmaz Aksoy; Turgut Yapanoğlu; İsa Özbey
Journal:  Eurasian J Med       Date:  2009-08

2.  Comparison of Patient Satisfaction with Treatment Outcomes between Ureteroscopy and Shock Wave Lithotripsy for Proximal Ureteral Stones.

Authors:  Jong-Hyun Lee; Seung Hyo Woo; Eun Tak Kim; Dae Kyung Kim; Jinsung Park
Journal:  Korean J Urol       Date:  2010-11-17

3.  Shock wave lithotripsy is effective and safe for distal ureteral calculi in children.

Authors:  Isa Ozbey; Yilmaz Aksoy; Tevfik Ziypak; Turgut Yapanoglu; Ozkan Polat; Mehmet Aksoy
Journal:  Urol Res       Date:  2007-08-01

4.  The effect of stone size on the results of extracorporeal shockwave lithotripsy versus semi-rigid ureteroscopic lithotripsy in the management of upper ureteric stones.

Authors:  Ahmed S El-Abd; Ahmed M Tawfeek; Shawky A El-Abd; Tarik A Gameel; Hasan H El-Tatawy; Magdy A El-Sabaa; Mohamed G Soliman
Journal:  Arab J Urol       Date:  2021-11-26

5.  Effect of Precision Health Education on Compliance Behavior after Extracorporeal Shock Wave Lithotripsy.

Authors:  Chan-Can Li; Zong-Wu Zhang
Journal:  Comput Math Methods Med       Date:  2022-09-14       Impact factor: 2.809

6.  Shock-wave lithotripsy in the elderly: Safety, efficacy and special considerations.

Authors:  Prodromos Philippou; D Lamrani; Konstantinos Moraitis; Hassan Wazait; Junaid Masood; Noor Buchholz
Journal:  Arab J Urol       Date:  2011-05-06

7.  Clinical experience with shock-wave lithotripsy using the Siemens Modularis Vario lithotripter.

Authors:  Mohamed E Hassouna; Samir Oraby; Wael Sameh; Ahmed El-Abbady
Journal:  Arab J Urol       Date:  2011-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.